Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

NCT06130995 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Androgen Deprivation Therapy
Locally Advanced Prostate Cancer

Interventions

DRUG: Relugolix and Enzalutamide

Sponsor

University of Oklahoma

Collaborators

[object Object]
[object Object]